发明名称 |
New carboxy-reduced and selectively O-sulfated chondroitin sulfate derivatives, useful for treating e.g. articular degeneration or disorders of bone metabolism, are inhibitors of matrix metalloproteases |
摘要 |
Isolated or mixed carboxy-reduced and chemoselectively O-sulfated derivatives (A) of chondroitin sulfate (CS) and their salts are new. An independent claim is also included for three methods for preparing (A). ACTIVITY : Antiarthritic; Vulnerary; Analgesic; Osteopathic; Antiinflammatory; Muscular-Gen.; Antirheumatic. MECHANISM OF ACTION : Metalloprotease inhibitor. Carboxy-reduced, persulfated CS had IC50 for inhibition of aggrecanase of 0.004 Microg/ml; inhibited factor Xa only weakly (1.2 units/mg; contrast 100 units /mg for reference heparin) and had IC50 against human MMP 2 and 7 of 0.4 Microg/ml. |
申请公布号 |
FR2864089(A1) |
申请公布日期 |
2005.06.24 |
申请号 |
FR20030014988 |
申请日期 |
2003.12.19 |
申请人 |
AVENTIS PHARMA SA |
发明人 |
ULMER WOLFGANG;VISKOV CHRISTIAN;HUBERT PHILIPPE |
分类号 |
A61K31/737;A61P19/02;C08B37/08 |
主分类号 |
A61K31/737 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|